First patient in Italy treated with TruBeam radiotherapy

25 Oct 2010

The Humanitas Clinic in Rozzano-Milan has treated the first person in Italy using a revolutionary new linear accelerator that can deliver radiotherapy twice as fast as conventional therapy machines.

The treatment was carried out on a 54-year-old head & neck cancer patient earlier this month using the TrueBeam from Varian Medical Systems (NYSE: VAR).

The patient, suffering from cancer of the rhino pharynx, received the required dose of radiotherapy in five treatment sessions using 2-arc RapidArc radiotherapy, after which clinicians said his symptoms had alleviated considerably.

“We are very satisfied with the progress to date and the patient appears to be responding well,” said Dr Marta Scorsetti, chief physician at the private clinic.

Dr. Scorsetti said the TrueBeam accelerator will be used to treat 50 patients a day and treatments will focus on hypo-fractionated stereotactic body radiotherapy (SBRT), in particular for liver and pancreatic cancer, non small-cell lung cancer and lymph-node metastases.

“TrueBeam will enable us to offer treatments for different kinds of pathologies than have previously been possible with radiosurgery here at Humanitas,” said Dr. Scorsetti. “In particular we will be able to treat patients with previously treated recurrences which could not have been re-treated otherwise.”

According to Dr Scorsetti, total bone marrow irradiation (TMI) is a good example of an innovative radiotherapy treatment made possible by TrueBeam. “We can provide fast total marrow irradiation with excellent quality using TrueBeam,” she said, adding that clinicians at Humanitas intend to commence such treatments in November, using the TrueBeam device to deliver RapidArc with eight arcs and four isocenters. TMI is carried out during the treatment of multiple myeloma, a cancer of plasma cells.

Dr Scorsetti said TrueBeam has many new features that will enable her to offer cancer patients more advanced care. Designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, the TrueBeam platform for image-guided radiotherapy and radiosurgery was introduced by Varian in April as the first fully-integrated system designed from the ground up to treat a moving target with unprecedented speed and accuracy.

RapidArc delivers a volumetric intensity-modulated radiation therapy (IMRT) treatment in a single or multiple arcs of the treatment machine around the patient and makes it possible to deliver advanced image-guided IMRT two to eight times faster than is possible with conventional IMRT.

“We are impressed by the greater precision and higher quality imaging, higher possible dose rate, the ability to deliver the total dose in fewer fractions and the speed of the treatment, which allows for more patient comfort with shorter treatment sessions,” she added.


To top